SCHEMBL9924330

SCHEMBL9924330

COc1ccc(C(=O)/N=C(/Nc2cc(F)cc(Cl)c2)NC2CCC(NC(=O)c3ccccc3)CC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.47
MAPK14 Q16539 1/20 0.45
KMT2A Q03164 7/20 0.44
CCR3 P51677 1/20 0.43
MEN1 O00255 5/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
KCNK9 Q9NPC2 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
DRD4 P21917 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CXCR6 O00574 1/20 0.40
KLK7 P49862 1/20 0.40
CCNE1 P24864 1/20 0.40
CDK2 P24941 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9924258 0.92 GRM5 (0.47) GRM5KMT2ACCR3MEN1KCNK9
SCHEMBL9924333 0.92 NPC1 (0.44) GRM5KMT2ACCR3MEN1L3MBTL1
SCHEMBL9924083 0.91 NPC1 (0.44) GRM5KMT2ACCR3MEN1L3MBTL1
SCHEMBL9924071 0.90 KMT2A (0.43) GRM5KMT2AMEN1CYP2C19NPC1
SCHEMBL9924332 0.89 SLC6A9 (0.41) GRM5MAPK14KMT2ACCR3MEN1
SCHEMBL9924457 0.87 NPC1 (0.43) GRM5KMT2ACCR3MEN1NPC1
SCHEMBL9924070 0.87 GRM4 (0.40) KMT2AMEN1ALDH1A1
SCHEMBL9924329 0.85 SLC6A9 (0.40) GRM5MAPK14KMT2ACCR3L3MBTL1
SCHEMBL9924257 0.83 GRM5 (0.42) GRM5KMT2ACCR3MEN1NPC1
SCHEMBL9924090 0.82 APOB (0.40) MAPK14KMT2AMEN1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169199-B2 Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2015-10-27 US disclosed
WO-2012078867-A2 CYCLOALKYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF LYCERA CORPORATION (US) 2012-06-14 WO disclosed